Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Short-term Investments: 2011-2017

Historic Short-term Investments for EyePoint Pharmaceuticals (EYPT) over the last 6 years, with Mar 2017 value amounting to $2.5 million.

  • EyePoint Pharmaceuticals' Short-term Investments fell 70.27% to $2.5 million in Q1 2017 from the same period last year, while for Mar 2017 it was $2.5 million, marking a year-over-year decrease of 70.27%. This contributed to the annual value of $13.7 million for FY2016, which is 45.30% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Short-term Investments of $2.5 million as of Q1 2017, which was down 57.26% from $5.8 million recorded in Q4 2016.
  • EyePoint Pharmaceuticals' Short-term Investments' 5-year high stood at $13.7 million during Q2 2016, with a 5-year trough of $502,000 in Q4 2013.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Short-term Investments value was $8.7 million (recorded in 2015), while the average stood at $8.5 million.
  • In the last 5 years, EyePoint Pharmaceuticals' Short-term Investments slumped by 92.05% in 2013 and then surged by 1,082.27% in 2014.
  • EyePoint Pharmaceuticals' Short-term Investments (Quarterly) stood at $502,000 in 2013, then soared by 1,082.27% to $5.9 million in 2014, then surged by 66.49% to $9.9 million in 2015, then plummeted by 40.83% to $5.8 million in 2016, then crashed by 70.27% to $2.5 million in 2017.
  • Its Short-term Investments was $2.5 million in Q1 2017, compared to $5.8 million in Q4 2016 and $8.2 million in Q3 2016.